Cheryl Ackert-Bicknell
Concepts (366)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 15 | 2024 | 242 | 3.540 |
Why?
| | Bone Density | 30 | 2023 | 486 | 3.020 |
Why?
| | Bone and Bones | 14 | 2023 | 317 | 1.990 |
Why?
| | Quantitative Trait Loci | 19 | 2022 | 381 | 1.810 |
Why?
| | Genome-Wide Association Study | 20 | 2023 | 1436 | 1.680 |
Why?
| | Osteoblasts | 14 | 2021 | 126 | 1.140 |
Why?
| | Zebrafish | 5 | 2024 | 496 | 1.000 |
Why?
| | Genetic Variation | 8 | 2019 | 986 | 0.870 |
Why?
| | Femur | 10 | 2018 | 263 | 0.830 |
Why?
| | Chromosome Mapping | 10 | 2019 | 523 | 0.810 |
Why?
| | Musculoskeletal Diseases | 2 | 2024 | 77 | 0.800 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 33 | 0.790 |
Why?
| | Intervertebral Disc | 1 | 2023 | 39 | 0.790 |
Why?
| | Intervertebral Disc Displacement | 1 | 2023 | 40 | 0.780 |
Why?
| | Mice | 55 | 2024 | 17843 | 0.780 |
Why?
| | Animals | 66 | 2024 | 37011 | 0.670 |
Why?
| | Osteoporotic Fractures | 2 | 2022 | 61 | 0.640 |
Why?
| | Spine | 2 | 2018 | 174 | 0.620 |
Why?
| | Genome | 3 | 2019 | 292 | 0.620 |
Why?
| | Insulin-Like Growth Factor I | 9 | 2008 | 316 | 0.600 |
Why?
| | Fracture Healing | 2 | 2016 | 82 | 0.590 |
Why?
| | Fractures, Bone | 4 | 2022 | 419 | 0.580 |
Why?
| | Skeleton | 1 | 2016 | 6 | 0.520 |
Why?
| | Mice, Inbred C57BL | 16 | 2020 | 5792 | 0.510 |
Why?
| | Alternative Splicing | 1 | 2018 | 227 | 0.510 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2021 | 2193 | 0.500 |
Why?
| | PPAR gamma | 5 | 2010 | 183 | 0.500 |
Why?
| | Phenotype | 19 | 2024 | 3205 | 0.500 |
Why?
| | Laboratory Animal Science | 1 | 2015 | 4 | 0.480 |
Why?
| | Diphosphonates | 1 | 2016 | 66 | 0.480 |
Why?
| | Bone Density Conservation Agents | 1 | 2016 | 80 | 0.470 |
Why?
| | Gene-Environment Interaction | 2 | 2013 | 194 | 0.460 |
Why?
| | Lipoproteins, HDL | 2 | 2013 | 77 | 0.410 |
Why?
| | Disease Models, Animal | 8 | 2024 | 4295 | 0.410 |
Why?
| | Body Composition | 6 | 2010 | 668 | 0.400 |
Why?
| | GATA Transcription Factors | 1 | 2012 | 7 | 0.380 |
Why?
| | Aging | 5 | 2021 | 1866 | 0.380 |
Why?
| | Hip | 1 | 2012 | 55 | 0.370 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 205 | 0.350 |
Why?
| | Mice, Inbred Strains | 9 | 2015 | 413 | 0.350 |
Why?
| | Mice, Inbred C3H | 9 | 2010 | 272 | 0.350 |
Why?
| | Thiazolidinediones | 2 | 2008 | 137 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 7 | 2022 | 2420 | 0.340 |
Why?
| | Chromosome Inversion | 2 | 2007 | 17 | 0.340 |
Why?
| | Dietary Fats | 2 | 2011 | 301 | 0.330 |
Why?
| | Transcription Factors | 4 | 2023 | 1717 | 0.330 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1507 | 0.330 |
Why?
| | Gene Regulatory Networks | 3 | 2021 | 308 | 0.330 |
Why?
| | Osteoarthritis | 2 | 2025 | 185 | 0.320 |
Why?
| | Crosses, Genetic | 6 | 2012 | 137 | 0.320 |
Why?
| | Carrier Proteins | 5 | 2017 | 770 | 0.290 |
Why?
| | Gene Expression Regulation | 9 | 2020 | 2615 | 0.280 |
Why?
| | Genetic Association Studies | 3 | 2016 | 377 | 0.270 |
Why?
| | Osteogenesis | 4 | 2021 | 187 | 0.270 |
Why?
| | Chromosomes, Mammalian | 4 | 2012 | 25 | 0.270 |
Why?
| | Humans | 39 | 2025 | 137514 | 0.260 |
Why?
| | Cell Differentiation | 6 | 2021 | 1979 | 0.260 |
Why?
| | CRISPR-Cas Systems | 2 | 2024 | 123 | 0.250 |
Why?
| | Mice, Knockout | 9 | 2020 | 3020 | 0.240 |
Why?
| | Genetic Pleiotropy | 2 | 2017 | 31 | 0.230 |
Why?
| | Pseudarthrosis | 1 | 2024 | 12 | 0.230 |
Why?
| | Diskectomy | 1 | 2024 | 23 | 0.230 |
Why?
| | Meta-Analysis as Topic | 2 | 2017 | 179 | 0.220 |
Why?
| | Synovial Membrane | 1 | 2025 | 117 | 0.220 |
Why?
| | Lipoproteins, LDL | 1 | 2024 | 119 | 0.220 |
Why?
| | Ankle Joint | 1 | 2025 | 110 | 0.220 |
Why?
| | Calcification, Physiologic | 2 | 2021 | 32 | 0.220 |
Why?
| | Bone Diseases | 2 | 2015 | 63 | 0.220 |
Why?
| | Adipose Tissue | 2 | 2007 | 624 | 0.210 |
Why?
| | X-Ray Microtomography | 4 | 2018 | 94 | 0.210 |
Why?
| | Allelic Imbalance | 1 | 2023 | 9 | 0.210 |
Why?
| | Longevity | 2 | 2015 | 165 | 0.210 |
Why?
| | Sarcopenia | 2 | 2024 | 82 | 0.210 |
Why?
| | Cervical Vertebrae | 1 | 2024 | 135 | 0.210 |
Why?
| | Organ Size | 4 | 2017 | 479 | 0.200 |
Why?
| | Craniosynostoses | 1 | 2023 | 57 | 0.200 |
Why?
| | Femoracetabular Impingement | 1 | 2022 | 36 | 0.190 |
Why?
| | Osteoarthritis, Hip | 1 | 2022 | 45 | 0.190 |
Why?
| | Behavior, Animal | 2 | 2016 | 514 | 0.190 |
Why?
| | Exons | 2 | 2018 | 349 | 0.190 |
Why?
| | HMGB1 Protein | 1 | 2022 | 50 | 0.190 |
Why?
| | Biology | 1 | 2023 | 87 | 0.190 |
Why?
| | Skull | 3 | 2023 | 139 | 0.190 |
Why?
| | Mammals | 1 | 2023 | 286 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2022 | 363 | 0.190 |
Why?
| | Regenerative Medicine | 1 | 2022 | 47 | 0.180 |
Why?
| | Zebrafish Proteins | 1 | 2024 | 287 | 0.180 |
Why?
| | Musculoskeletal System | 1 | 2022 | 48 | 0.180 |
Why?
| | Transcriptome | 6 | 2025 | 974 | 0.180 |
Why?
| | Spinal Fusion | 1 | 2024 | 251 | 0.180 |
Why?
| | Erythropoietin | 1 | 2022 | 95 | 0.180 |
Why?
| | Bone Marrow | 2 | 2015 | 286 | 0.180 |
Why?
| | Genotype | 5 | 2018 | 1920 | 0.180 |
Why?
| | Anemia | 1 | 2022 | 171 | 0.170 |
Why?
| | Antibody-Producing Cells | 1 | 2020 | 30 | 0.170 |
Why?
| | Male | 28 | 2025 | 67718 | 0.170 |
Why?
| | Female | 35 | 2025 | 73162 | 0.170 |
Why?
| | Muscle Weakness | 1 | 2021 | 87 | 0.170 |
Why?
| | Adipogenesis | 2 | 2010 | 52 | 0.160 |
Why?
| | Computational Biology | 2 | 2021 | 645 | 0.160 |
Why?
| | Cell Separation | 1 | 2021 | 320 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 146 | 0.160 |
Why?
| | Tetraspanins | 1 | 2019 | 19 | 0.160 |
Why?
| | Cartilage, Articular | 1 | 2022 | 309 | 0.150 |
Why?
| | Untranslated Regions | 1 | 2018 | 3 | 0.150 |
Why?
| | Promoter Regions, Genetic | 2 | 2018 | 1255 | 0.150 |
Why?
| | Sex Characteristics | 2 | 2018 | 766 | 0.150 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 50 | 0.150 |
Why?
| | Information Management | 1 | 2018 | 18 | 0.150 |
Why?
| | Osteomyelitis | 1 | 2020 | 137 | 0.140 |
Why?
| | Musculoskeletal Development | 1 | 2017 | 2 | 0.140 |
Why?
| | Cell Line | 5 | 2018 | 2852 | 0.140 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 58 | 0.140 |
Why?
| | Genetic Markers | 2 | 2016 | 345 | 0.140 |
Why?
| | Calcaneus | 1 | 2017 | 31 | 0.140 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 8 | 0.140 |
Why?
| | Quantitative Trait, Heritable | 2 | 2018 | 126 | 0.140 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 215 | 0.130 |
Why?
| | Receptor, EphB2 | 1 | 2016 | 4 | 0.130 |
Why?
| | Excitatory Amino Acid Transporter 1 | 1 | 2016 | 6 | 0.130 |
Why?
| | Nuclear Proteins | 3 | 2011 | 710 | 0.130 |
Why?
| | Species Specificity | 5 | 2014 | 593 | 0.130 |
Why?
| | Wnt Proteins | 2 | 2015 | 133 | 0.130 |
Why?
| | Animals, Outbred Strains | 1 | 2016 | 5 | 0.130 |
Why?
| | Glycoproteins | 3 | 2003 | 345 | 0.130 |
Why?
| | Leukocytes | 1 | 2018 | 311 | 0.130 |
Why?
| | Retinal Vessels | 1 | 2017 | 69 | 0.130 |
Why?
| | Histological Techniques | 1 | 2016 | 40 | 0.130 |
Why?
| | Minerals | 1 | 2016 | 42 | 0.130 |
Why?
| | Mutagenesis | 1 | 2017 | 182 | 0.130 |
Why?
| | Pelvic Bones | 1 | 2019 | 162 | 0.120 |
Why?
| | Databases, Genetic | 2 | 2014 | 237 | 0.120 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 452 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2020 | 886 | 0.120 |
Why?
| | Sepsis | 1 | 2022 | 611 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 366 | 0.120 |
Why?
| | Rodent Diseases | 1 | 2015 | 28 | 0.120 |
Why?
| | Animal Structures | 1 | 2015 | 9 | 0.120 |
Why?
| | Stem Cells | 2 | 2022 | 589 | 0.120 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 402 | 0.120 |
Why?
| | Spinal Fractures | 1 | 2016 | 84 | 0.120 |
Why?
| | Bone Resorption | 1 | 2016 | 86 | 0.120 |
Why?
| | Haplotypes | 3 | 2012 | 491 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 856 | 0.120 |
Why?
| | Linkage Disequilibrium | 3 | 2021 | 268 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2017 | 1770 | 0.110 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2015 | 66 | 0.110 |
Why?
| | Rats | 1 | 2023 | 5676 | 0.110 |
Why?
| | Face | 1 | 2015 | 175 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 66 | 0.110 |
Why?
| | Urination | 1 | 2014 | 45 | 0.110 |
Why?
| | Mice, Transgenic | 3 | 2015 | 2182 | 0.110 |
Why?
| | Urodynamics | 1 | 2014 | 44 | 0.110 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1458 | 0.110 |
Why?
| | Inbreeding | 2 | 2011 | 18 | 0.110 |
Why?
| | Animals, Newborn | 4 | 2021 | 845 | 0.100 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 14 | 0.100 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2014 | 60 | 0.100 |
Why?
| | Genome, Human | 1 | 2015 | 424 | 0.100 |
Why?
| | Actins | 2 | 2024 | 416 | 0.100 |
Why?
| | Genomics | 3 | 2015 | 793 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2024 | 2641 | 0.100 |
Why?
| | Ovariectomy | 2 | 2011 | 150 | 0.100 |
Why?
| | Adipocytes | 3 | 2010 | 215 | 0.100 |
Why?
| | Bone Marrow Cells | 4 | 2010 | 313 | 0.100 |
Why?
| | Cohort Studies | 4 | 2024 | 5730 | 0.100 |
Why?
| | Databases, Factual | 1 | 2018 | 1351 | 0.100 |
Why?
| | Lod Score | 1 | 2012 | 67 | 0.100 |
Why?
| | RNA Editing | 1 | 2012 | 24 | 0.100 |
Why?
| | Sequence Analysis, DNA | 3 | 2015 | 812 | 0.100 |
Why?
| | Stromal Cells | 4 | 2006 | 111 | 0.090 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 40 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2015 | 504 | 0.090 |
Why?
| | Liver | 6 | 2012 | 1940 | 0.090 |
Why?
| | Environment | 1 | 2013 | 362 | 0.090 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 145 | 0.090 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 220 | 0.090 |
Why?
| | Inflammation | 2 | 2022 | 2837 | 0.090 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 57 | 0.090 |
Why?
| | MEF2 Transcription Factors | 1 | 2010 | 61 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 501 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 696 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3292 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2838 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 451 | 0.080 |
Why?
| | Circadian Rhythm | 2 | 2010 | 463 | 0.080 |
Why?
| | Estrogens | 1 | 2012 | 361 | 0.080 |
Why?
| | Bone Development | 2 | 2014 | 54 | 0.080 |
Why?
| | Research Design | 1 | 2015 | 1116 | 0.080 |
Why?
| | Mice, Inbred DBA | 1 | 2008 | 200 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 425 | 0.070 |
Why?
| | Aged | 6 | 2025 | 23798 | 0.070 |
Why?
| | Gene Expression | 4 | 2019 | 1505 | 0.070 |
Why?
| | RNA, Messenger | 7 | 2019 | 2838 | 0.070 |
Why?
| | Alleles | 2 | 2008 | 891 | 0.070 |
Why?
| | Models, Animal | 2 | 2014 | 387 | 0.070 |
Why?
| | Europe | 2 | 2021 | 414 | 0.070 |
Why?
| | Somatomedins | 1 | 2006 | 27 | 0.070 |
Why?
| | Molecular Sequence Annotation | 2 | 2017 | 97 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2020 | 4206 | 0.060 |
Why?
| | Muscle, Skeletal | 3 | 2024 | 1701 | 0.060 |
Why?
| | Bone Remodeling | 1 | 2006 | 74 | 0.060 |
Why?
| | Mutation | 1 | 2017 | 3964 | 0.060 |
Why?
| | Keratins | 1 | 2006 | 173 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 704 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2025 | 3546 | 0.060 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2024 | 7 | 0.060 |
Why?
| | Mammary Glands, Animal | 1 | 2006 | 129 | 0.060 |
Why?
| | Morphogenesis | 1 | 2006 | 166 | 0.060 |
Why?
| | MyoD Protein | 1 | 2024 | 35 | 0.060 |
Why?
| | Fish Oils | 1 | 2024 | 26 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2974 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2024 | 116 | 0.060 |
Why?
| | Granulosa Cell Tumor | 1 | 2003 | 5 | 0.050 |
Why?
| | Muscular Diseases | 1 | 2024 | 115 | 0.050 |
Why?
| | Muscle Development | 1 | 2024 | 111 | 0.050 |
Why?
| | X Chromosome | 1 | 2003 | 53 | 0.050 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2003 | 24 | 0.050 |
Why?
| | Larva | 1 | 2024 | 221 | 0.050 |
Why?
| | Adiposity | 1 | 2008 | 517 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 33355 | 0.050 |
Why?
| | Transcription Initiation Site | 1 | 2023 | 43 | 0.050 |
Why?
| | Oncogenes | 1 | 2003 | 117 | 0.050 |
Why?
| | Uncertainty | 1 | 2023 | 127 | 0.050 |
Why?
| | Lipids | 1 | 2007 | 664 | 0.050 |
Why?
| | Osteoclasts | 2 | 2017 | 52 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2022 | 20 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2005 | 658 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 974 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 54 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2023 | 403 | 0.050 |
Why?
| | Body Weight | 3 | 2017 | 973 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 429 | 0.050 |
Why?
| | Gene Ontology | 1 | 2021 | 53 | 0.050 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2021 | 3 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2024 | 511 | 0.040 |
Why?
| | Bone Matrix | 1 | 2021 | 5 | 0.040 |
Why?
| | HLA-DQ alpha-Chains | 1 | 2021 | 16 | 0.040 |
Why?
| | Adult | 5 | 2025 | 37821 | 0.040 |
Why?
| | Hip Joint | 1 | 2022 | 170 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2022 | 268 | 0.040 |
Why?
| | Gene Frequency | 2 | 2015 | 521 | 0.040 |
Why?
| | Growth Hormone | 3 | 2006 | 101 | 0.040 |
Why?
| | Wnt4 Protein | 1 | 2020 | 18 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 442 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2008 | 1285 | 0.040 |
Why?
| | Cortical Bone | 1 | 2019 | 18 | 0.040 |
Why?
| | ROC Curve | 1 | 2020 | 547 | 0.040 |
Why?
| | Bifidobacterium longum | 1 | 2018 | 6 | 0.040 |
Why?
| | Calcium | 1 | 2024 | 1233 | 0.040 |
Why?
| | Prospective Studies | 2 | 2025 | 7598 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2003 | 914 | 0.040 |
Why?
| | Muscle Strength | 1 | 2021 | 315 | 0.040 |
Why?
| | Glypicans | 1 | 2017 | 11 | 0.040 |
Why?
| | Oligosaccharides | 1 | 2018 | 61 | 0.040 |
Why?
| | Hip Fractures | 1 | 2019 | 95 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2022 | 418 | 0.030 |
Why?
| | Ovarian Neoplasms | 1 | 2003 | 563 | 0.030 |
Why?
| | Osteochondrodysplasias | 1 | 2017 | 18 | 0.030 |
Why?
| | Osteocytes | 1 | 2017 | 28 | 0.030 |
Why?
| | Electroretinography | 1 | 2017 | 48 | 0.030 |
Why?
| | Growth Disorders | 1 | 2017 | 86 | 0.030 |
Why?
| | Cancellous Bone | 1 | 2016 | 23 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 203 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 180 | 0.030 |
Why?
| | Genetic Loci | 1 | 2018 | 288 | 0.030 |
Why?
| | RNA | 1 | 2022 | 924 | 0.030 |
Why?
| | Mice, Congenic | 2 | 2006 | 23 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1061 | 0.030 |
Why?
| | Cryopreservation | 1 | 2016 | 98 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 765 | 0.030 |
Why?
| | Age Factors | 2 | 2018 | 3301 | 0.030 |
Why?
| | Base Sequence | 2 | 2012 | 2180 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 300 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 1029 | 0.030 |
Why?
| | Mice, Inbred NZB | 2 | 2006 | 16 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 193 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2755 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2039 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 245 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 268 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2901 | 0.030 |
Why?
| | Exome | 1 | 2015 | 231 | 0.030 |
Why?
| | Tibial Fractures | 1 | 2015 | 75 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 660 | 0.030 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 2 | 2004 | 26 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1524 | 0.030 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 2 | 2003 | 9 | 0.030 |
Why?
| | Osteoprotegerin | 2 | 2003 | 24 | 0.030 |
Why?
| | RANK Ligand | 2 | 2003 | 29 | 0.030 |
Why?
| | Upper Extremity | 1 | 2014 | 102 | 0.030 |
Why?
| | Fibrosis | 1 | 2015 | 552 | 0.030 |
Why?
| | Biopsy | 1 | 2016 | 1132 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2003 | 164 | 0.020 |
Why?
| | Child | 3 | 2018 | 22037 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2012 | 68 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 252 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 344 | 0.020 |
Why?
| | Models, Biological | 2 | 2010 | 1775 | 0.020 |
Why?
| | Litter Size | 1 | 2011 | 17 | 0.020 |
Why?
| | Software | 1 | 2016 | 670 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 15 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 2004 | 768 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2010 | 35 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1548 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1271 | 0.020 |
Why?
| | Lower Extremity | 1 | 2014 | 427 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2010 | 123 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2010 | 138 | 0.020 |
Why?
| | Lipoproteins | 1 | 2010 | 168 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2074 | 0.020 |
Why?
| | Risk Factors | 2 | 2016 | 10356 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2010 | 502 | 0.020 |
Why?
| | Meiosis | 1 | 2009 | 81 | 0.020 |
Why?
| | Chromosomes | 1 | 2009 | 108 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7593 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4172 | 0.020 |
Why?
| | Bayes Theorem | 1 | 2010 | 407 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 346 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2010 | 275 | 0.020 |
Why?
| | Dissection | 1 | 2007 | 53 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 4 | 1 | 2006 | 4 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 8 | 0.020 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2006 | 22 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 39 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 15628 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2006 | 65 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2857 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 116 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2007 | 299 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6059 | 0.020 |
Why?
| | Receptors, Somatotropin | 1 | 2005 | 9 | 0.020 |
Why?
| | Cholesterol | 1 | 2007 | 413 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 345 | 0.010 |
Why?
| | DNA Primers | 1 | 2006 | 514 | 0.010 |
Why?
| | Triglycerides | 1 | 2007 | 525 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 784 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2006 | 475 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 948 | 0.010 |
Why?
| | Down-Regulation | 1 | 2006 | 658 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2004 | 148 | 0.010 |
Why?
| | Nitric Oxide Donors | 1 | 2003 | 21 | 0.010 |
Why?
| | Radiography | 1 | 2006 | 834 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 2003 | 37 | 0.010 |
Why?
| | Nitroprusside | 1 | 2003 | 69 | 0.010 |
Why?
| | Brain | 1 | 2016 | 2831 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9467 | 0.010 |
Why?
| | Cyclic GMP | 1 | 2003 | 94 | 0.010 |
Why?
| | Calcitriol | 1 | 2003 | 58 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1227 | 0.010 |
Why?
| | Parathyroid Hormone | 1 | 2003 | 108 | 0.010 |
Why?
| | Algorithms | 1 | 2010 | 1702 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11097 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2003 | 198 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 898 | 0.010 |
Why?
| | Human Growth Hormone | 1 | 2002 | 46 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 6745 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 1740 | 0.010 |
Why?
| | Tibia | 1 | 2002 | 177 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 845 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1357 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1679 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 694 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 21555 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 13243 | 0.010 |
Why?
| | Signal Transduction | 1 | 2006 | 5096 | 0.010 |
Why?
|
|
Ackert-Bicknell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|